A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006)
Clinical trial NCT01613248 · COMPLETED
Trial details
- NCT number
- NCT01613248
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2012-12-01
- Enrollment
- 834
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.